Pharmaceutical firms require efficient technologies such as Internet of Things (IoT), cloud computing, artificial intelligence and big data to manage info that is important to the development and production of successful drugs. As a result, pharmaceutical corporations are increasing their investment on varied security products to stop breaches, protect patient data and secure sensitive information.
According to a survey, 79% of pharmaceutical firms are presently investments in identity and access management (IAM) solutions and 72% of firms are considering investment in the solutions over consequent two years.
Investments in IAM solutions among pharmaceutical firms are driven by the necessity to manage electronic user identities and guarantee data privacy whereas avoiding any misuse of vital business information. The survey further reveals that equal proportion (75%) of pharmaceutical companies are presently deploying some kind of backup and archiving, and content and internet filtering solutions to store as well as preserve their online information.
Furthermore, organizations are endeavoring to deploy IoT to attenuate human intervention and reach enhanced quality control. Although the pharmaceutical sector lags behind in implementing cyber security, prevalence of data sharing is compelling firms to look for vendors that may offer integrated security operations and analytics to tackle abnormal behavior.